Polypill with aspirin ‘preferred for CVD prevention’
Whether polypills include aspirin or not, they will be a key strategy for primary prevention, researcher says.
AusDoc brings you the latest news from the European Society of Cardiology Congress 2021.
Use of fixed dose combination therapies for primary prevention could mean millions of major CVD events are avoided every year, and the addition of aspirin makes them even more effective, Canadian researchers say.
Professor Philip Joseph of McMaster University in Hamilton, Ontario, Canada reported the results of an individual patient level meta-analysis of three large polypill trials to the ESC Congress 2021, and results were simultaneously published in the Lancet.
“About 80% of cardiovascular disease events occur in individuals without prior vascular disease,” Professor Joseph said.
